A Phase 3 Study of Orelabrutinib to Delay Disability Progression in Patients with Non‑Active Secondary Progressive Multiple Sclerosis
- Substances:–
Denmark- Participants:18–64 years
- Sponsor:Zenas Biopharma (USA) LLC
Rare diseases
Investigational molecules
Locations
Back to Denmark50 clinical trials in Viborg, Denmark across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in DenmarkKliniske-Forsoeg.dk(opens in a new tab)
DenmarkOrelabrutinib in Patients with Primary Progressive Multiple Sclerosis
DenmarkStudy of laroprovstat (AZD0780) to reduce heart attack, stroke and vascular complications in patients with atherosclerotic cardiovascular disease or high risk of developing it
Denmark
DenmarkStudy on Selatogrel for Preventing Heart Attack in Patients with Recent Heart Attack History
DenmarkPhase 2 study of MK-7262 and enlicitide decanoate in adults with high lipoprotein(a)
DenmarkZodasiran for Adolescents With Homozygous Familial Hypercholesterolemia: A Phase 3 Study of Efficacy and Safety
DenmarkStudy of Zenagamtide (NNC0487-0111) versus placebo in patients with heart failure with preserved or mildly reduced ejection fraction and obesity
DenmarkA Study of Olpasiran for Patients With Stable Heart and Blood Vessel Disease and High Lipoprotein(a) to Measure Changes in Artery Plaque Using Heart Scans
Denmark
DenmarkComparison of remifentanil and rocuronium for improving video laryngoscopy assisted tracheal intubation in adult patients undergoing general anesthesia
DenmarkStudy of AP31969 compared to placebo to control heart rhythm in patients with atrial fibrillation
DenmarkThe busiest research cities in the country
What the registry says about research in the country
Groundbreaking trials focused on heart failure prevention and treatment of acute coronary syndromes. Studies evaluating novel therapies for reducing cardiovascular events and managing atherosclerotic disease.
Multiple investigations exploring innovative approaches to prevent stroke and manage cardiovascular complications.
Clinical research examining treatments for acute interstitial nephritis and evaluating new approaches for patients requiring hemodialysis care.
Focus on improving outcomes for patients with various forms of kidney disease and related conditions.
Advanced research into multiple sclerosis treatments and migraine management, including both preventive and acute therapeutic approaches.
Innovative trials comparing established and novel treatments for neurological conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.